Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Alih fungsi RS kusta jadi museum bisa hilangkan stigma, tapi mengapa sulit diterapkan di Indonesia?

● Kuatnya stereotip negatif masyarakat maupun tenaga kesehatan, menghambat upaya pemberantasan kusta di Tanah Air.● Alih fungsi RS kusta menjadi museum bisa meningkatkan upaya menghilangka...

Jangan asal cepat, membangun huntara dan huntap bagi penyintas banjir Sumatra perlu memperhatikan 3 hal ini

● Membangun hunian pascabencana tidak bisa sekadar cepat dan aman secara fisik.● Relokasi harus mempertimbangkan mata pencaharian, akses sosial, dan layanan dasar, agar warga tidak kehilan...

Program televisi dari AI: Inovasi teknologi atau degradasi seni?

● Program ‘Legenda Bertuah’ menjadi pionir tayangan televisi di Indonesia yang memanfaatkan AI secara penuh.● Penggunaan teknologi ini memicu kritik terkait potensi hilangnya k...